Kopran - Quaterly Results

27 Oct 2021 Evaluate
The company witnessed a 19.44% growth in the revenue at Rs. 562.25 millions for the quarter ended September 2021 as compared to Rs. 470.73 millions during the year-ago period.Net profit of the cmpany stood at Rs. 37.76 millions for the quarter ended September 2021 a decline of -49.57% from Rs. 74.88 millions  in the same quarter last year.Operating Profit reported a sharp decline to 65.72 millions from 126.69 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 562.25 470.73 19.44 854.45 1043.06 -18.08 2228.33 1792.91 24.29
Other Income 19.72 32.64 -39.58 43.23 56.59 -23.61 104.14 19.90 423.32
PBIDT 65.72 126.69 -48.13 94.45 235.09 -59.82 406.14 251.66 61.38
Interest 5.26 11.15 -52.83 11.81 25.72 -54.08 38.07 59.62 -36.15
PBDT 60.46 115.54 -47.67 82.64 209.37 -60.53 368.07 192.04 91.66
Depreciation 10.88 10.49 3.72 21.65 20.05 7.98 41.03 34.72 18.17
PBT 49.58 105.05 -52.80 60.99 189.32 -67.78 327.04 157.32 107.88
TAX 11.82 30.17 -60.82 14.52 54.24 -73.23 92.33 45.13 104.59
Deferred Tax 3.05 11.72 -73.98 3.76 21.27 -82.32 34.76 17.12 103.04
PAT 37.76 74.88 -49.57 46.47 135.08 -65.60 234.71 112.19 109.21
Equity 432.52 432.49 0.01 432.52 432.49 0.01 432.52 432.49 0.01
PBIDTM(%) 11.69 26.91 -56.57 11.05 22.54 -50.96 18.23 14.04 29.85

Kopran Share Price

142.55 -2.50 (-1.72%)
19-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1673.55
Dr. Reddys Lab 1166.45
Cipla 1391.20
Zydus Lifesciences 881.10
Lupin 2178.20
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×